Online citations, reference lists, and bibliographies.
Please confirm you are human
(Sign Up for free to never see this)
← Back to Search

Role Of The Retinoid X Receptors In Skeletal Muscle Development

M. May
Published 2011 · Biology

Save to my Library
Download PDF
Analyze on Scholarcy
Share
Pluripotent stem cells have the capacity to develop into different cell lineages and can be manipulated into certain cell types through the use of small molecule inducers. Retinoic acid (RA) signaling through retinoic acid receptors (RAR) and retinoid X receptors (RXR) has the ability to direct lineage determination but has yielded disappointing results in promoting skeletal myogenesis in embryonic stem (ES) cells. RXR is crucial in embryonic development although it is generally considered to act as a silent partner for other nuclear receptors such as RAR. Our findings demonstrate that rexinoid specific signaling enhances skeletal myogenesis and requires β-catenin but not RAR. Moreover, RXR signalling in mouse ES cells can efficiently enhance skeletal myogenesis and closely recapitulates sequential events observed in vivo. Since ES cells closely represent the properties of the developing embryo, efficiently generating skeletal muscle provides a means to further scrutinize signaling pathways in myogenic development in view of developing therapies for muscle related diseases.
This paper references
10.1007/BF00304424
Early stages of chick somite development
B. Christ (2004)
10.1126/SCIENCE.290.5499.2140
Docosahexaenoic acid, a ligand for the retinoid X receptor in mouse brain.
A. M. de Urquiza (2000)
10.1126/SCIENCE.1136244
A Membrane Receptor for Retinol Binding Protein Mediates Cellular Uptake of Vitamin A
R. Kawaguchi (2007)
10.1074/jbc.R600015200
Wnt Signaling: Multiple Pathways, Multiple Receptors, and Multiple Transcription Factors*
M. D. Gordon (2006)
10.1074/JBC.M011491200
Pax3 Is Essential for Skeletal Myogenesis and the Expression of Six1 and Eya2*
A. G. Ridgeway (2001)
10.1021/BI980561R
Heterodimer formation by retinoid X receptor: regulation by ligands and by the receptor's self-association properties.
D. Dong (1998)
Retinoids : the biochemical and molecular basis of Vitamin A and retinoid action
H. Nau (1999)
A beta-catenin/engrailed chimera selectively suppresses Wnt signaling.
W. T. Montross (2000)
10.1242/dev.01537
Gli2 and Gli3 have redundant and context-dependent function in skeletal muscle formation
A. McDermott (2005)
10.1101/GAD.1424806
Sensors and signals: a coactivator/corepressor/epigenetic code for integrating signal-dependent programs of transcriptional response.
M. Rosenfeld (2006)
10.1007/s00280-009-1140-4
Bexarotene: a promising anticancer agent
Liyan Qu (2009)
10.1387/IJDB.10761860
Abnormalities of somite development in the absence of retinoic acid.
M. Maden (2000)
10.1006/DBIO.1996.0087
Bone morphogenetic protein-2 (BMP-2) inhibits muscle development and promotes cartilage formation in chick limb bud cultures.
Dominique Duprez (1996)
10.1146/ANNUREV.CELLBIO.14.1.167
Transcriptional control of muscle development by myocyte enhancer factor-2 (MEF2) proteins.
B. Black (1998)
10.1038/358587A0
Homodimer formation of retinoid X receptor induced by 9-cis retinoic acid
X. Zhang (1992)
10.1101/GAD.4.9.1454
MyoD family: a paradigm for development?
E. Olson (1990)
A conserved region of engrailed, shared among all en-, gsc-, Nk1-, Nk2- and msh-class homeoproteins, mediates active transcriptional repression in vivo.
S. Smith (1996)
Pax-3 expression in segmental mesoderm marks early stages in myogenic cell specification.
B. Williams (1994)
10.1002/j.1460-2075.1995.tb07101.x
Inactivation of Myf‐6 and Myf‐5 genes in mice leads to alterations in skeletal muscle development.
T. Braun (1995)
10.1523/JNEUROSCI.15-08-05727.1995
Expression of mef2 genes in the mouse central nervous system suggests a role in neuronal maturation
G. Lyons (1995)
10.1038/371528A0
Regulation of retinoid signalling by receptor polarity and allosteric control of ligand binding
R. Kurokawa (1994)
10.1002/jcb.10310
Retinoid signalling and gene expression in neuroblastoma cells: RXR agonist and antagonist effects on CRABP‐II and RARβ expression
Q. C. Hewson (2002)
10.1073/PNAS.72.4.1441
Differentiation of clonal lines of teratocarcinoma cells: formation of embryoid bodies in vitro.
G. R. Martin (1975)
10.1101/GAD.382806
A novel genetic hierarchy functions during hypaxial myogenesis: Pax3 directly activates Myf5 in muscle progenitor cells in the limb.
L. Bajard (2006)
10.1038/nature04277
Embryonic and extraembryonic stem cell lines derived from single mouse blastomeres
Y. Chung (2006)
Early expression of the myogenic regulatory gene, myf-5, in precursor cells of skeletal muscle in the mouse embryo.
M. Ott (1991)
10.1093/NAR/27.17.3603
Expression of the utrophin gene during myogenic differentiation.
A. Gramolini (1999)
10.1016/0092-8674(93)90610-3
The MyoD family and myogenesis: Redundancy, networks, and thresholds
H. Weintraub (1993)
10.1016/0092-8674(88)90017-7
The estrogen receptor binds tightly to its responsive element as a ligand-induced homodimer
V. Kumar (1988)
10.1002/stem.251
A Novel Signaling by Vitamin A/Retinol Promotes Self Renewal of Mouse Embryonic Stem Cells by Activating PI3K/Akt Signaling Pathway via Insulin‐Like Growth Factor‐1 Receptor
L. Chen (2010)
10.1210/MEND.16.5.0823
Molecular recognition of agonist ligands by RXRs.
P. Egea (2002)
10.1038/sj.cdd.4401533
Retinoid X receptors: X-ploring their (patho)physiological functions
A. Szanto (2004)
10.1016/S1097-2765(00)80424-4
Crystal structure of a heterodimeric complex of RAR and RXR ligand-binding domains.
W. Bourguet (2000)
10.1016/0092-8674(92)90507-9
Targeted inactivation of the muscle regulatory gene Myf-5 results in abnormal rib development and perinatal death
T. Braun (1992)
10.1074/JBC.272.18.11744
Identification and Characterization of a Stereospecific Human Enzyme That Catalyzes 9-cis-Retinol Oxidation
J. Mertz (1997)
10.1006/DBIO.1997.8713
A role for WNT proteins in induction of dermomyotome.
C. Fan (1997)
10.1016/0092-8674(93)90621-V
MyoD or Myf-5 is required for the formation of skeletal muscle
M. Rudnicki (1993)
10.1016/s0074-7696(08)61566-1
Retinoids and mammalian development.
G. Morriss-Kay (1999)
10.1038/nrg2340
Retinoic acid in development: towards an integrated view
K. Niederreither (2008)
10.1038/7788
Embryonic retinoic acid synthesis is essential for early mouse post-implantation development
K. Niederreither (1999)
10.1083/JCB.94.2.253
Retinoic acid induces embryonal carcinoma cells to differentiate into neurons and glial cells
E. Jones-Villeneuve (1982)
10.1101/GAD.802300
Structural basis for autorepression of retinoid X receptor by tetramer formation and the AF-2 helix.
R. Gampe (2000)
10.1074/JBC.M312612200
Disruption of Meox or Gli Activity Ablates Skeletal Myogenesis in P19 Cells*
H. Petropoulos (2004)
10.1016/S1097-2765(02)00481-1
Promoter-specific regulation of MyoD binding and signal transduction cooperate to pattern gene expression.
D. Bergstrom (2002)
10.1016/0092-8674(81)90018-0
A direct repeat in the cellular retinol-binding protein type II gene confers differential regulation by RXR and RAR
D. Mangelsdorf (1991)
10.1083/JCB.139.3.735
Specific and Redundant Functions of Retinoid X Receptor/Retinoic Acid Receptor Heterodimers in Differentiation, Proliferation, and Apoptosis of F9 Embryonal Carcinoma Cells
H. Chiba (1997)
RA enhances skeletal myogenesis in both P 19 and ES cells by increasing the expression of Wnt 3 a , Pax 3 and Meox 1 through binding to RARs in the regulatory regions of these genes
K. A. Kennedy (2009)
10.1038/292154A0
Establishment in culture of pluripotential cells from mouse embryos
M. Evans (1981)
10.1152/ajpcell.1999.276.5.C1069
An E-box within the MHC IIB gene is bound by MyoD and is required for gene expression in fast muscle.
M. T. Wheeler (1999)
10.1074/jbc.M608813200
Kinetic and Mass Spectrometric Analysis of p300 Histone Acetyltransferase Domain Autoacetylation*
Balasubramanyam Karanam (2006)
10.1038/ng876
Genetic evidence that oxidative derivatives of retinoic acid are not involved in retinoid signaling during mouse development
K. Niederreither (2002)
10.1128/MCB.13.9.5133
An E box mediates activation and repression of the acetylcholine receptor delta-subunit gene during myogenesis.
A. M. Simon (1993)
Disruption of the mouse MRF4 gene identifies multiple waves of myogenesis in the myotome.
A. Patapoutian (1995)
Mef2 gene expression marks the cardiac and skeletal muscle lineages during mouse embryogenesis.
D. Edmondson (1994)
Sonic hedgehog controls epaxial muscle determination through Myf5 activation.
A. Borycki (1999)
10.1073/PNAS.90.4.1546
MEF2C, a MADS/MEF2-family transcription factor expressed in a laminar distribution in cerebral cortex.
D. Leifer (1993)
10.1128/MCB.3.12.2271
Retinoic acid-induced neural differentiation of embryonal carcinoma cells.
E. Jones-Villeneuve (1983)
10.1016/0092-8674(93)90246-M
Function of retinoic acid receptor γ in the mouse
D. Lohnes (1993)
MyoD expression marks the onset of skeletal myogenesis in Myf-5 mutant mice.
T. Braun (1994)
10.1194/JLR.R100015-JLR200
Gene expression regulation by retinoic acid Published, JLR Papers in Press, August 16, 2002. DOI 10.1194/jlr.R100015-JLR200
J. Balmer (2002)
10.1016/S0960-9822(02)00509-2
Vitamin A-deficient quail embryos have half a hindbrain and other neural defects
M. Maden (1996)
10.1038/sj.onc.1201484
Functional specificity of the two retinoic acid receptor RAR and RXR families in myogenesis
S. Alric (1998)
Cervical Dysplasia Regression Induced by Acid
M. Sporn (1994)
10.1016/0012-1606(85)90342-2
Cell-cell interaction can influence drug-induced differentiation of murine embryonal carcinoma cells.
J. Campione-Piccardo (1985)
10.1128/MCB.18.5.2804
Two Distinct Types of Repression Domain in Engrailed: One Interacts with the Groucho Corepressor and Is Preferentially Active on Integrated Target Genes
E. Tolkunova (1998)
10.1016/J.GDE.2005.04.015
Mechanisms underlying the transcriptional regulation of skeletal myogenesis.
V. Sartorelli (2005)
10.1038/382819A0
Two distinct actions of retinoid-receptor ligands
J. Chen (1996)
10.1016/0092-8674(87)90585-X
Expression of a single transfected cDNA converts fibroblasts to myoblasts
R. Davis (1987)
10.1016/0092-8674(92)90508-A
Inactivation of MyoD in mice leads to up-regulation of the myogenic HLH gene Myf-5 and results in apparently normal muscle development
M. Rudnicki (1992)
10.1083/JCB.128.4.563
Myogenin is required for late but not early aspects of myogenesis during mouse development
J. Venuti (1995)
10.1159/000016699
Induction of Cellular Differentiation by Retinoic Acid in vitro
J. Rohwedel (1999)
10.1021/BI952737K
Individual subunits of heterodimers comprised of retinoic acid and retinoid X receptors interact with their ligands independently.
S. Kersten (1996)
10.1002/JCB.240530107
Bone morphogenetic protein inhibits differentiation and affects expression of helix‐loop‐helix regulatory molecules in myoblastic cells
S. Murray (1993)
10.1242/dev.01773
Six1 and Six4 homeoproteins are required for Pax3 and Mrf expression during myogenesis in the mouse embryo
Raphaelle Grifone (2005)
10.1016/S0925-4773(99)00311-1
BMP2 is required for early heart development during a distinct time period
T. Schlange (2000)
10.1101/GAD.11.3.289
Unique requirements for retinoid-dependent transcriptional activation by the orphan receptor LXR.
P. J. Willy (1997)
10.1128/MCB.17.2.644
Retinoid X receptor (RXR) within the RXR-retinoic acid receptor heterodimer binds its ligand and enhances retinoid-dependent gene expression.
S. Minucci (1997)
10.1016/0168-9525(92)90373-C
Making muscle in mammals.
M. Buckingham (1992)
10.1083/JCB.113.6.1255
The muscle regulatory gene, Myf-6, has a biphasic pattern of expression during early mouse development
E. Bober (1991)
10.1210/ENDO.133.5.8404668
9-cis-retinoic acid regulates the expression of the muscle determination gene Myf5.
G. Carnac (1993)
10.1016/S1534-5807(03)00263-6
Intrinsic, Hox-dependent cues determine the fate of skeletal muscle precursors.
L. E. Alvares (2003)
10.1074/jbc.271.15.9009
Human p300 Protein Is a Coactivator for the Transcription Factor MyoD (*)
W. Yuan (1996)
10.1016/S0008-6363(97)00193-4
Embryonic stem cells: a model to study structural and functional properties in cardiomyogenesis.
J. Hescheler (1997)
10.1128/MCB.12.3.1031
HEB, a helix-loop-helix protein related to E2A and ITF2 that can modulate the DNA-binding ability of myogenic regulatory factors.
J. Hu (1992)
10.1002/j.1460-2075.1989.tb03429.x
A novel human muscle factor related to but distinct from MyoD1 induces myogenic conversion in 10T1/2 fibroblasts.
T. Braun (1989)
Differential activation of Myf5 and MyoD by different Wnts in explants of mouse paraxial mesoderm and the later activation of myogenesis in the absence of Myf5.
S. Tajbakhsh (1998)
10.1006/DBIO.1997.8687
Defects of the Chorioallantoic Placenta in Mouse RXRα Null Fetuses
V. Sapin (1997)
10.1146/ANNUREV.CELLBIO.14.1.59
Mechanisms of Wnt signaling in development.
A. Wodarz (1998)
10.1101/GAD.940702
Myf5 is a direct target of long-range Shh signaling and Gli regulation for muscle specification.
M. Gustafsson (2002)
10.1128/MCB.02404-05
MyoD Synergizes with the E-Protein HEBβ To Induce Myogenic Differentiation
M. Parker (2006)
10.1016/S0092-8674(00)80189-0
Redefining the Genetic Hierarchies Controlling Skeletal Myogenesis: Pax-3 and Myf-5 Act Upstream of MyoD
S. Tajbakhsh (1997)
10.1016/S0092-8674(00)80521-8
Activation of p53 Sequence-Specific DNA Binding by Acetylation of the p53 C-Terminal Domain
W. Gu (1997)
10.1038/366340A0
The retinoid ligand 4-oxo-retinoic acid is a highly active modulator of positional specification
W. P. Pijnappel (1993)
10.1016/0092-8674(89)90051-2
Determinants of target gene specificity for steroid/thyroid hormone receptors
K. Umesono (1989)
10.1074/jbc.272.5.2722
Identification of a Retinoid/Chicken Ovalbumin Upstream Promoter Transcription Factor Response Element in the Human Retinoid X Receptor γ2 Gene Promoter*
P. Barger (1997)
10.1038/299165A0
Control of muscle and neuronal differentiation in a cultured embryonal carcinoma cell line
M. McBurney (1982)
10.1016/S1097-2765(00)80383-4
Acetylation of MyoD directed by PCAF is necessary for the execution of the muscle program.
V. Sartorelli (1999)
10.1093/emboj/19.16.4342
Both corepressor proteins SMRT and N‐CoR exist in large protein complexes containing HDAC3
J. Li (2000)
10.1016/0968-0004(92)90014-Z
Multiplicity generates diversity in the retinoic acid signalling pathways.
M. Leid (1992)
Specification of the hypaxial musculature.
S. Dietrich (1998)
10.1073/PNAS.87.21.8442
MyoD induces growth arrest independent of differentiation in normal and transformed cells.
M. Crescenzi (1990)
10.1016/S1097-2765(00)80448-7
Asymmetry in the PPARγ/RXRα Crystal Structure Reveals the Molecular Basis of Heterodimerization among Nuclear Receptors
R. Gampe (2000)
10.1101/GAD.9.23.2911
Combinatorial signaling by Sonic hedgehog and Wnt family members induces myogenic bHLH gene expression in the somite.
A. Münsterberg (1995)
10.1016/S0959-437X(98)80008-7
Muscle differentiation: more complexity to the network of myogenic regulators.
H. Arnold (1998)
10.1038/352497A0
Crystallographic analysis of the interaction of the glucocorticoid receptor with DNA
B. Luisi (1991)
10.1038/364532A0
Myogenin gene disruption results in perinatal lethality because of severe muscle defect
Y. Nabeshima (1993)
10.1126/SCIENCE.280.5367.1274
Distinct WNT pathways regulating AER formation and dorsoventral polarity in the chick limb bud.
M. Kengaku (1998)
10.1242/dev.02517
The Wnt/β-catenin pathway regulates Gli-mediated Myf5 expression during somitogenesis
U. Borello (2006)
Function of retinoic acid receptor gamma in the mouse.
D. Lohnes (1993)
10.1128/MCB.10.12.6445
A dominant negative mutation of the alpha retinoic acid receptor gene in a retinoic acid-nonresponsive embryonal carcinoma cell.
M. A. C. Pratt (1990)
10.1093/NAR/21.2.335
Regulation of the mouse desmin gene: transactivated by MyoD, myogenin, MRF4 and Myf5.
H. Li (1993)
10.1016/S0092-8674(00)80190-7
Ectopic Pax-3 Activates MyoD and Myf-5 Expression in Embryonic Mesoderm and Neural Tissue
M. Maroto (1997)
10.1016/J.GENE.2003.12.005
Nuclear retinoid receptors and the transcription of retinoid-target genes.
J. Bastien (2004)
10.1101/GAD.9.9.1033
LXR, a nuclear receptor that defines a distinct retinoid response pathway.
P. J. Willy (1995)
10.1016/S1040-8428(01)00144-5
Retinoids and their receptors in cancer development and chemoprevention.
S. Sun (2002)
10.1002/j.1460-2075.1990.tb08179.x
Myf‐6, a new member of the human gene family of myogenic determination factors: evidence for a gene cluster on chromosome 12.
T. Braun (1990)
10.1016/0092-8674(95)90199-X
The nuclear receptor superfamily: The second decade
D. Mangelsdorf (1995)
10.1634/stemcells.2006-0615
Efficient Establishment of Mouse Embryonic Stem Cell Lines from Single Blastomeres and Polar Bodies
S. Wakayama (2007)
10.1621/nrs.07006
Developmental expression of retinoic acid receptors (RARs)
P. Dollé (2009)
10.1016/S0074-7696(08)61566-1
Retinoids and mammalian development.
Morriss-Kay Gm (1999)
10.1016/S1050-1738(99)00017-1
Cardiac and skeletal muscle development in P19 embryonal carcinoma cells.
I. Skerjanc (1999)
10.1016/S0955-0674(99)00036-8
MEF2: a transcriptional target for signaling pathways controlling skeletal muscle growth and differentiation.
F. Naya (1999)
10.1038/376768A0
Essential role for the c-met receptor in the migration of myogenic precursor cells into the limb bud
F. Bladt (1995)
10.1128/MCB.17.4.2166
Peroxisome proliferator-activated receptors and retinoic acid receptors differentially control the interactions of retinoid X receptor heterodimers with ligands, coactivators, and corepressors.
J. DiRenzo (1997)
10.1016/S0092-8674(00)82001-2
The Transcriptional Coactivators p300 and CBP Are Histone Acetyltransferases
V. Ogryzko (1996)
MyoD synergizes with the E-protein HEB beta to induce myogenic differentiation.
M. Parker (2006)
10.1016/0092-8674(89)90050-0
Two amino acids within the knuckle of the first zinc finger specify DNA response element activation by the glucocorticoid receptor
M. Danielsen (1989)
10.1016/0092-8674(94)90274-7
Genetic analysis of RXRα developmental function: Convergence of RXR and RAR signaling pathways in heart and eye morphogenesis
P. Kastner (1994)
10.1242/dev.00687
The concerted action of Meox homeobox genes is required upstream of genetic pathways essential for the formation, patterning and differentiation of somites
B. Mankoo (2003)
10.1093/emboj/20.23.6816
CBP/p300 and muscle differentiation: no HAT, no muscle
A. Polesskaya (2001)
10.1128/MCB.15.12.6481
Synergistic activation of retinoic acid (RA)-responsive genes and induction of embryonal carcinoma cell differentiation by an RA receptor alpha (RAR alpha)-, RAR beta-, or RAR gamma-selective ligand in combination with a retinoid X receptor-specific ligand.
B. Roy (1995)
10.1101/GAD.14.9.1048
A core SMRT corepressor complex containing HDAC3 and TBL1, a WD40-repeat protein linked to deafness.
M. Guenther (2000)
10.1074/jbc.M003815200
CREB-binding Protein/p300 Activates MyoD by Acetylation*
A. Polesskaya (2000)
10.1038/345813A0
Cell proliferation inhibited by MyoD1 independently of myogenic differentiation
V. Sorrentino (1990)
10.1093/emboj/16.18.5697
A mutation mimicking ligand‐induced conformational change yields a constitutive RXR that senses allosteric effects in heterodimers
V. Vivat (1997)
10.1101/GAD.8.9.1007
RXR alpha mutant mice establish a genetic basis for vitamin A signaling in heart morphogenesis.
H. Sucov (1994)
Brachyury is expressed by human teratocarcinoma cells in the absence of mesodermal differentiation.
P. Gokhale (2000)
10.1038/375377A0
Crystal structure of the ligand-binding domain of the human nuclear receptor RXR-α
W. Bourguet (1995)
10.1016/0092-8674(89)90838-6
Positive autoregulation of the myogenic determination gene MyoD1
M. Thayer (1989)
10.1093/emboj/19.11.2592
Crystal structure of the human RXRα ligand‐binding domain bound to its natural ligand: 9‐cis retinoic acid
P. Egea (2000)
10.1016/S1097-2765(00)80005-2
Differential roles of p300 and PCAF acetyltransferases in muscle differentiation.
P. L. Puri (1997)
10.1002/j.1460-2075.1988.tb03168.x
The N‐terminal DNA‐binding ‘zinc finger’ of the oestrogen and glucocorticoid receptors determines target gene specificity.
S. Green (1988)
10.1016/0092-8674(89)90434-0
Interactions between heterologous helix-loop-helix proteins generate complexes that bind specifically to a common DNA sequence
C. Murre (1989)
10.1186/1741-7007-7-67
Retinoic acid enhances skeletal muscle progenitor formation and bypasses inhibition by bone morphogenetic protein 4 but not dominant negative β-catenin
Karen AM Kennedy (2009)
10.1101/GAD.13.24.3198
Molecular determinants of nuclear receptor-corepressor interaction.
V. Perissi (1999)
10.1073/PNAS.95.8.4404
The identification of a 9-cis retinol dehydrogenase in the mouse embryo reveals a pathway for synthesis of 9-cis retinoic acid.
A. Romert (1998)
10.1038/364501A0
Muscle deficiency and neonatal death in mice with a targeted mutation in the myogenin gene
P. Hasty (1993)
Asymmetry in the PPARgamma/RXRalpha crystal structure reveals the molecular basis of heterodimerization among nuclear receptors.
R. Gampe (2000)
10.1128/MCB.11.1.267
Muscle-specific expression of the troponin I gene requires interactions between helix-loop-helix muscle regulatory factors and ubiquitous transcription factors.
H. Lin (1991)
10.1128/MCB.11.10.4854
Myogenin induces the myocyte-specific enhancer binding factor MEF-2 independently of other muscle-specific gene products.
P. Cserjesi (1991)
10.1101/GAD.6.3.329
Characterization of three RXR genes that mediate the action of 9-cis retinoic acid.
D. Mangelsdorf (1992)
10.1093/emboj/cdg473
Differential role of p300 and CBP acetyltransferase during myogenesis: p300 acts upstream of MyoD and Myf5
J. Roth (2003)
10.1016/S0008-6363(02)00771-X
Twenty one years of P19 cells: what an embryonal carcinoma cell line taught us about cardiomyocyte differentiation.
M. V. D. van der Heyden (2003)
10.1006/EXCR.1996.0154
Dominant negative mutant of retinoic acid receptor alpha inhibits retinoic acid-induced P19 cell differentiation by binding to DNA.
S. Costa (1996)
10.1016/0012-1606(87)90133-3
Commitment to differentiation induced by retinoic acid in P19 embryonal carcinoma cells is cell cycle dependent.
C. Mummery (1987)
10.1016/0092-8674(87)90646-5
Site-directed mutagenesis by gene targeting in mouse embryo-derived stem cells
K. Thomas (1987)
10.1016/S0303-7207(97)00217-7
Ligand-inducible retinoid X receptor-mediated protein: DNA interactions in the retinoic acid receptor β2 gene promoter in vivo
M. Ikeda (1998)
10.1101/gad.4.8.1450
A gene with homology to the myc similarity region of MyoD1 is expressed during myogenesis and is sufficient to activate the muscle differentiation program.
D. Edmondson (1990)
Defects of the chorioallantoic placenta in mouse RXRalpha null fetuses.
V. Sapin (1997)
10.1073/PNAS.90.15.7225
High postnatal lethality and testis degeneration in retinoic acid receptor alpha mutant mice.
T. Lufkin (1993)
10.1038/sj.emboj.7600209
In vivo activation of PPAR target genes by RXR homodimers
A. Ijpenberg (2004)
10.1242/dev.00557
Myf5 expression in somites and limb buds of mouse embryos is controlled by two distinct distal enhancer activities
A. Buchberger (2003)
10.1046/j.1469-7580.2003.00139.x
The formation of skeletal muscle: from somite to limb
M. Buckingham (2003)
10.1006/DBIO.1994.1347
Activation of Xenopus MyoD transcription by members of the MEF2 protein family.
M. W. Wong (1994)
Crystal structure of the human RXRalpha ligand-binding domain bound to its natural ligand: 9-cis retinoic acid.
P. Egea (2000)
10.1038/sj.onc.1201894
Retinoic acid receptors and muscle b-HLH proteins: partners in retinoid-induced myogenesis
A. Froeschlé (1998)
10.1038/26040
Interactions controlling the assembly of nuclear-receptor heterodimers and co-activators
S. Westin (1998)
10.1016/S0092-8674(00)81291-X
Lateral and Axial Signals Involved in Avian Somite Patterning: A Role for BMP4
O. Pourquié (1996)
10.1146/ANNUREV.PHARMTOX.46.120604.141156
Function of retinoid nuclear receptors: lessons from genetic and pharmacological dissections of the retinoic acid signaling pathway during mouse embryogenesis.
M. Mark (2006)
10.1016/S0378-1119(00)00161-X
Groucho/TLE family proteins and transcriptional repression.
G. Chen (2000)
The retinoid X receptor and its ligands: versatile regulators of metabolic function, cell differentiation and cell death.
H. Ahuja (2003)
10.1074/jbc.M307123200
Concomitant Increase of Histone Acetyltransferase Activity and Degradation of p300 during Retinoic Acid-induced Differentiation of F9 Cells*
F. Brouillard (2003)
[Transport and metabolism of vitamin A].
S. V. Chetyrkin (2000)
10.1016/0092-8674(95)90202-3
Nonsteroid nuclear receptors: What Are genetic studies telling us about their role in real life?
P. Kastner (1995)
10.1016/0925-4773(96)00597-7
Nuclear localization of β-catenin by interaction with transcription factor LEF-1
O. Huber (1996)
10.1016/S0955-0674(99)80031-3
Regulation of LEF-1/TCF transcription factors by Wnt and other signals.
Q. Eastman (1999)
10.1006/BBRC.1994.1585
Expression of retinoid X receptors in P19 embryonal carcinoma cells and embryonic stem cells.
G. Bain (1994)
10.1038/341303A0
Expression of two myogenic regulatory factors myogenin and MyoDl during mouse embryogenesis
D. Sassoon (1989)
10.1387/IJDB.9032023
Differential localization of Mox-1 and Mox-2 proteins indicates distinct roles during development.
Albert F. Candia (1996)
10.1074/JBC.M100916200
Role of Intronic E- and N-box Motifs in the Transcriptional Induction of the Acetylcholinesterase Gene during Myogenic Differentiation*
L. Angus (2001)
10.1101/GAD.8.1.1
bHLH factors in muscle development: dead lines and commitments, what to leave in and what to leave out.
E. Olson (1994)
10.1073/PNAS.92.19.8645
Retinoid X receptor alpha forms tetramers in solution.
S. Kersten (1995)
Phase 2 and 3 clinical trial of oral bexarotene (Targretin capsules) for the treatment of refractory or persistent early-stage cutaneous T-cell lymphoma.
M. Duvic (2001)
10.1101/gad.1689808
Pluripotent stem cell lines.
J. Yu (2008)
10.1128/MCB.16.9.5058
E-box sites and a proximal regulatory region of the muscle creatine kinase gene differentially regulate expression in diverse skeletal muscles and cardiac muscle of transgenic mice.
M. Shield (1996)
10.1038/382319A0
A p300/CBP-associated factor that competes with the adenoviral oncoprotein E1A
Xiang-Jiao Yang (1996)
10.1126/SCIENCE.1335166
Retinoids selective for retinoid X receptor response pathways.
J. Lehmann (1992)
The role of SF/HGF and c-Met in the development of skeletal muscle.
S. Dietrich (1999)
10.1101/GAD.9.7.769
A novel pathway for vitamin A signaling mediated by RXR heterodimerization with NGFI-B and NURR1.
T. Perlmann (1995)
10.1016/J.YEXCR.2005.09.011
Response of human rhabdomyosarcoma cell lines to retinoic acid: relationship with induction of differentiation and retinoic acid sensitivity.
Stéphanie Ricaud (2005)
10.1182/BLOOD.V84.11.3781.BLOODJOURNAL84113781
Absence of WAF1 mutations in a variety of human malignancies.
M. Shiohara (1994)
Deregulated expression of the retinoid X receptor alpha prevents muscle differentiation in P19 embryonal carcinoma cells.
M. A. C. Pratt (1998)
10.1074/jbc.R000025200
CREB-binding Protein and p300 in Transcriptional Regulation*
N. Vo (2001)
10.1128/MCB.21.7.2404-2412.2001
Molecular Distinction between Specification and Differentiation in the Myogenic Basic Helix-Loop-Helix Transcription Factor Family
D. Bergstrom (2001)
10.1073/pnas.1231422100
Retinoid activation of retinoic acid receptor but not retinoid X receptor is sufficient to rescue lethal defect in retinoic acid synthesis
F. Mic (2003)
10.1093/emboj/16.2.369
p300 is required for MyoD‐dependent cell cycle arrest and muscle‐specific gene transcription
P. L. Puri (1997)
10.1038/338271A0
Three amino acids of the oestrogen receptor are essential to its ability to distinguish an oestrogen from a glucocorticoid-responsive element
S. Mader (1989)
10.1074/jbc.275.1.41
Myocyte Enhancer Factor 2C and Myogenin Up-regulate Each Other's Expression and Induce the Development of Skeletal Muscle in P19 Cells*
A. G. Ridgeway (2000)
10.1101/GAD.11.4.451
A role for bone morphogenetic proteins in the induction of cardiac myogenesis.
T. Schultheiss (1997)
10.1210/ME.2007-0107
Orphan receptor TR3 attenuates the p300-induced acetylation of retinoid X receptor-alpha.
Wen-xiu Zhao (2007)
10.1073/PNAS.91.2.747
Mouse limb muscle is determined in the absence of the earliest myogenic factor myf-5.
S. Tajbakhsh (1994)
10.1093/emboj/18.24.6867
Wnt signaling and the activation of myogenesis in mammals
G. Cossu (1999)
Suppression of mammary tumorigenesis in transgenic mice by the RXR-selective retinoid, LGD1069.
K. Wu (2002)
10.1074/jbc.M701700200
p21WAF1/CIP1 Is a Common Transcriptional Target of Retinoid Receptors
T. Tanaka (2007)
10.1128/MCB.19.9.6448
A Novel Role for Helix 12 of Retinoid X Receptor in Regulating Repression
J. Zhang (1999)
Regulation of Pax-3 expression in the dermomyotome and its role in muscle development.
M. Goulding (1994)
When grown as undifferentiated monolayers , P 19 cells express stem cell specific markers such as SSEA - 1 (
C. L. Mummery (1975)
10.1517/13543784.11.2.159
Therapeutic potential of the
O. Levy (2002)
10.1007/s11626-999-0023-7
Factors in serum regulate muscle development in P19 cells
S. Wilton (1999)
10.1038/309255A0
Formation of germ-line chimaeras from embryo-derived teratocarcinoma cell lines
A. Bradley (1984)
Mox-1 and Mox-2 define a novel homeobox gene subfamily and are differentially expressed during early mesodermal patterning in mouse embryos.
Albert F. Candia (1992)
10.1158/0008-5472.CAN-08-4407
Therapeutic potential of "rexinoids" in cancer prevention and treatment.
T. Tanaka (2009)
Activation of the skeletal alpha-actin promoter during muscle regeneration.
D. Marsh (1998)
10.1128/MCB.17.2.1010
Molecular mechanisms of myogenic coactivation by p300: direct interaction with the activation domain of MyoD and with the MADS box of MEF2C.
V. Sartorelli (1997)
10.1002/j.1460-2075.1991.tb07663.x
Active repression of transcription by the engrailed homeodomain protein.
J. Jaynes (1991)
10.1074/jbc.274.12.8129
Interaction between the Skeletal Muscle Type 1 Na+Channel Promoter E-box and an Upstream Repressor Element
S. Kraner (1999)
10.1016/S0070-2153(08)60756-5
Genetics of muscle determination and development.
H. Arnold (2000)
10.1038/21892
Mox2 is a component of the genetic hierarchy controlling limb muscle development
B. Mankoo (1999)
10.1016/0092-8674(95)90075-6
Unique response pathways are established by allosteric interactions among nuclear hormone receptors
B. Forman (1995)
10.1073/PNAS.93.9.4213
Pax3 modulates expression of the c-Met receptor during limb muscle development.
J. Epstein (1996)
10.1073/PNAS.0404192101
In vitro transcription system delineates the distinct roles of the coactivators pCAF and p300 during MyoD/E47-dependent transactivation.
F. J. Dilworth (2004)
10.1074/JBC.M112141200
β-Catenin Is Essential and Sufficient for Skeletal Myogenesis in P19 Cells*
H. Petropoulos (2002)
10.1038/415187a
Co-regulator recruitment and the mechanism of retinoic acid receptor synergy
P. Germain (2002)
10.1038/nrm1744
Developmental cell biology: Regulatory networks in embryo-derived pluripotent stem cells
M. Boiani (2005)
Polyunsaturated fatty acids including docosahexaenoic and arachidonic acid bind to the retinoid X receptor alpha ligand-binding domain.
J. Lengqvist (2004)
10.1006/EXCR.1996.0291
9-cis-retinoic acid induces neuronal differentiation of retinoic acid-nonresponsive embryonal carcinoma cells.
Y. Yokota (1996)
10.1038/nature02876
Mrf4 determines skeletal muscle identity in Myf5:Myod double-mutant mice
L. Kassar-Duchossoy (2004)
10.1016/0092-8674(74)90090-7
The morphology and growth of a pluripotent teratocarcinoma cell line and its derivatives in tissue culture.
G. R. Martin (1974)
10.1038/383450A0
Activation of specific RXR heterodimers by an antagonist of RXR homodimers
D. Lala (1996)
10.1101/GAD.10.19.2478
Interaction and functional collaboration of p300/CBP and bHLH proteins in muscle and B-cell differentiation.
R. Eckner (1996)



Semantic Scholar Logo Some data provided by SemanticScholar